US Stock MarketDetailed Quotes

Avalo Therapeutics (AVTX)

Watchlist

13.660
-0.550-3.87%

Close Apr 10 16:00 ET

13.660
0.0000.00%

Post 17:16 ET

311.29MMarket Cap-2.34P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avalo Therapeutics (AVTX) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

-86.62%59K

-69.27%59K

-77.08%441K

-66.37%192K

5.51%249K

Operating revenue

-86.62%59K

-69.27%59K

--0

-77.08%441K

-66.37%192K

5.51%249K

--0

Cost of revenue

-128.50%-366K

139.37%87K

-389.07%-714K

-51.55%343K

-114.52%-80K

Gross profit

-92.69%59K

-43.81%59K

26.09%807K

-86.74%105K

8,854.55%963K

-427.69%-343K

205.26%80K

Operating expense

75.11%72.98M

47.59%19.8M

38.87%19.2M

111.59%19.32M

176.30%14.67M

73.05%41.68M

195.31%13.42M

269.72%13.82M

28.85%9.13M

-39.09%5.31M

Selling and administrative expenses

32.82%22.9M

24.86%6.53M

30.12%5.58M

15.77%5.24M

73.69%5.55M

67.39%17.24M

95.55%5.23M

72.13%4.29M

86.57%4.53M

17.91%3.19M

-Selling and marketing expense

-40.43%470K

-22.09%381K

-84.51%22K

166.67%56K

71.43%12K

2,290.91%789K

--489K

--142K

200.00%21K

-46.15%7K

-General and administrative expense

36.34%22.43M

29.70%6.15M

34.05%5.56M

15.07%5.19M

73.70%5.53M

60.24%16.45M

79.49%4.74M

66.43%4.14M

86.24%4.51M

18.22%3.19M

Research and development costs

104.95%50.08M

62.13%13.27M

42.81%13.62M

205.89%14.07M

331.14%9.12M

77.29%24.44M

338.30%8.18M

663.65%9.54M

-1.22%4.6M

-64.78%2.12M

Operating profit

-78.43%-72.93M

-48.31%-19.74M

-49.27%-19.2M

-103.93%-19.32M

-180.53%-14.67M

-74.33%-40.87M

-254.87%-13.31M

-242.96%-12.86M

-32.48%-9.47M

40.53%-5.23M

Net non-operating interest income expense

31.37%4.35M

-18.74%984K

15.87%1.12M

6.06%1.1M

1,048.00%1.15M

196.93%3.31M

1,395.06%1.21M

162.07%964K

204.32%1.04M

110.54%100K

Non-operating interest income

----

15.87%1.12M

6.06%1.1M

1,048.00%1.15M

----

--964K

--1.04M

--100K

Total other finance cost

-31.37%-4.35M

----

-196.93%-3.31M

-1,401.23%-1.22M

-162.07%-964K

-204.32%-1.04M

----

Other net income (expense)

-474.21%-9.52M

122.35%5.17M

-135.89%-12.53M

-102.37%-2.54M

100.33%380K

154.49%2.54M

-413.09%-23.13M

41,972.29%34.92M

267,357.50%106.9M

-56,285.44%-116.15M

Gain on sale of security

-124.16%-9.52M

122.31%5.16M

-135.88%-12.53M

-102.36%-2.53M

100.48%380K

5,572.92%39.41M

-3,755.00%-23.13M

34,825.00%34.93M

267,615.00%107.01M

-44,008.89%-79.4M

Special income (charges)

--0

-843.46%-36.86M

-135.99%-9.22M

--0

---103K

---27.54M

-Less：Restructuring and merger&acquisition

--0

----

--9.22M

----

-Less:Impairment of capital assets

----

--0

----

-Less:Other special charges

----

--27.64M

--0

----

--103K

--27.54M

Other non- operating income (expenses)

----

40.00%-3K

---5K

----

88.10%-5K

--9.22M

70.59%-5K

----

-35,361.54%-9.22M

Income before tax

-123.03%-78.09M

61.42%-13.59M

-232.97%-30.61M

-121.07%-20.75M

89.17%-13.14M

-11.05%-35.02M

-330.78%-35.23M

541.05%23.02M

1,302.91%98.47M

-1,119.29%-121.28M

Income tax

44.74%165K

14.04%130K

178.57%11K

128.57%16K

14.29%8K

714.29%114K

1,366.67%114K

-275.00%-14K

0.00%7K

-12.50%7K

Net income

-122.78%-78.26M

61.18%-13.72M

-232.94%-30.63M

-121.09%-20.77M

89.16%-13.15M

-11.37%-35.13M

-332.65%-35.34M

540.65%23.04M

1,301.79%98.46M

-1,118.38%-121.29M

Net income continuous Operations

-122.78%-78.26M

61.18%-13.72M

-232.94%-30.63M

-121.09%-20.77M

89.16%-13.15M

-11.37%-35.13M

-332.65%-35.34M

540.65%23.04M

1,301.79%98.46M

-1,118.38%-121.29M

Minority interest income

Net income attributable to the parent company

-122.78%-78.26M

61.18%-13.72M

-232.94%-30.63M

-121.09%-20.77M

89.16%-13.15M

-11.37%-35.13M

-332.65%-35.34M

540.65%23.04M

1,301.79%98.46M

-1,118.38%-121.29M

Preferred stock dividends

Other preferred stock dividends

17.58M

94.11M

Net income attributable to common stockholders

-122.78%-78.26M

60.98%-13.72M

-660.69%-30.63M

-576.92%-20.77M

89.16%-13.15M

-11.37%-35.13M

-330.48%-35.16M

204.48%5.46M

153.14%4.35M

-1,118.38%-121.29M

Basic earnings per share

26.45%-5.84

88.98%-0.37

-323.47%-2.19

-145.61%-1.92

99.11%-1.25

93.01%-7.94

67.04%-3.3577

103.65%0.98

102.99%4.21

30.81%-141.14

Diluted earnings per share

72.07%-5.84

88.98%-0.37

22.61%-2.19

86.35%-1.92

99.11%-1.25

81.59%-20.91

67.04%-3.3577

89.45%-2.83

90.00%-14.07

30.81%-141.14

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	-86.62%59K	-69.27%59K	0	0	0	-77.08%441K	-66.37%192K	5.51%249K	0	0
Operating revenue	-86.62%59K	-69.27%59K	--0	--0	--0	-77.08%441K	-66.37%192K	5.51%249K	--0	--0
Cost of revenue	0	0	0	0	0	-128.50%-366K	139.37%87K	-389.07%-714K	-51.55%343K	-114.52%-80K
Gross profit	-92.69%59K	-43.81%59K	0	0	0	26.09%807K	-86.74%105K	8,854.55%963K	-427.69%-343K	205.26%80K
Operating expense	75.11%72.98M	47.59%19.8M	38.87%19.2M	111.59%19.32M	176.30%14.67M	73.05%41.68M	195.31%13.42M	269.72%13.82M	28.85%9.13M	-39.09%5.31M
Selling and administrative expenses	32.82%22.9M	24.86%6.53M	30.12%5.58M	15.77%5.24M	73.69%5.55M	67.39%17.24M	95.55%5.23M	72.13%4.29M	86.57%4.53M	17.91%3.19M
-Selling and marketing expense	-40.43%470K	-22.09%381K	-84.51%22K	166.67%56K	71.43%12K	2,290.91%789K	--489K	--142K	200.00%21K	-46.15%7K
-General and administrative expense	36.34%22.43M	29.70%6.15M	34.05%5.56M	15.07%5.19M	73.70%5.53M	60.24%16.45M	79.49%4.74M	66.43%4.14M	86.24%4.51M	18.22%3.19M
Research and development costs	104.95%50.08M	62.13%13.27M	42.81%13.62M	205.89%14.07M	331.14%9.12M	77.29%24.44M	338.30%8.18M	663.65%9.54M	-1.22%4.6M	-64.78%2.12M
Operating profit	-78.43%-72.93M	-48.31%-19.74M	-49.27%-19.2M	-103.93%-19.32M	-180.53%-14.67M	-74.33%-40.87M	-254.87%-13.31M	-242.96%-12.86M	-32.48%-9.47M	40.53%-5.23M
Net non-operating interest income expense	31.37%4.35M	-18.74%984K	15.87%1.12M	6.06%1.1M	1,048.00%1.15M	196.93%3.31M	1,395.06%1.21M	162.07%964K	204.32%1.04M	110.54%100K
Non-operating interest income	----	----	15.87%1.12M	6.06%1.1M	1,048.00%1.15M	----	----	--964K	--1.04M	--100K
Total other finance cost	-31.37%-4.35M	----	----	----	----	-196.93%-3.31M	-1,401.23%-1.22M	-162.07%-964K	-204.32%-1.04M	----
Other net income (expense)	-474.21%-9.52M	122.35%5.17M	-135.89%-12.53M	-102.37%-2.54M	100.33%380K	154.49%2.54M	-413.09%-23.13M	41,972.29%34.92M	267,357.50%106.9M	-56,285.44%-116.15M
Gain on sale of security	-124.16%-9.52M	122.31%5.16M	-135.88%-12.53M	-102.36%-2.53M	100.48%380K	5,572.92%39.41M	-3,755.00%-23.13M	34,825.00%34.93M	267,615.00%107.01M	-44,008.89%-79.4M
Special income (charges)	--0	--0	--0	--0	--0	-843.46%-36.86M	-135.99%-9.22M	--0	---103K	---27.54M
-Less：Restructuring and merger&acquisition	--0	----	----	----	----	--9.22M	----	----	----	----
-Less:Impairment of capital assets	----	----	----	----	----	--0	----	----	----	----
-Less:Other special charges	----	----	----	----	----	--27.64M	--0	----	--103K	--27.54M
Other non- operating income (expenses)	----	----	40.00%-3K	---5K	----	88.10%-5K	--9.22M	70.59%-5K	----	-35,361.54%-9.22M
Income before tax	-123.03%-78.09M	61.42%-13.59M	-232.97%-30.61M	-121.07%-20.75M	89.17%-13.14M	-11.05%-35.02M	-330.78%-35.23M	541.05%23.02M	1,302.91%98.47M	-1,119.29%-121.28M
Income tax	44.74%165K	14.04%130K	178.57%11K	128.57%16K	14.29%8K	714.29%114K	1,366.67%114K	-275.00%-14K	0.00%7K	-12.50%7K
Net income	-122.78%-78.26M	61.18%-13.72M	-232.94%-30.63M	-121.09%-20.77M	89.16%-13.15M	-11.37%-35.13M	-332.65%-35.34M	540.65%23.04M	1,301.79%98.46M	-1,118.38%-121.29M
Net income continuous Operations	-122.78%-78.26M	61.18%-13.72M	-232.94%-30.63M	-121.09%-20.77M	89.16%-13.15M	-11.37%-35.13M	-332.65%-35.34M	540.65%23.04M	1,301.79%98.46M	-1,118.38%-121.29M
Minority interest income
Net income attributable to the parent company	-122.78%-78.26M	61.18%-13.72M	-232.94%-30.63M	-121.09%-20.77M	89.16%-13.15M	-11.37%-35.13M	-332.65%-35.34M	540.65%23.04M	1,301.79%98.46M	-1,118.38%-121.29M
Preferred stock dividends
Other preferred stock dividends								17.58M	94.11M
Net income attributable to common stockholders	-122.78%-78.26M	60.98%-13.72M	-660.69%-30.63M	-576.92%-20.77M	89.16%-13.15M	-11.37%-35.13M	-330.48%-35.16M	204.48%5.46M	153.14%4.35M	-1,118.38%-121.29M
Basic earnings per share	26.45%-5.84	88.98%-0.37	-323.47%-2.19	-145.61%-1.92	99.11%-1.25	93.01%-7.94	67.04%-3.3577	103.65%0.98	102.99%4.21	30.81%-141.14
Diluted earnings per share	72.07%-5.84	88.98%-0.37	22.61%-2.19	86.35%-1.92	99.11%-1.25	81.59%-20.91	67.04%-3.3577	89.45%-2.83	90.00%-14.07	30.81%-141.14
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm